Electroconvulsive therapy for depression in a patient with an inspire hypoglossal nerve stimulator device for obstructive sleep apnea: A case report

Obstructive sleep apnea (OSA) is a common disorder that affects 5–10% of the US adult population [1]. Affected patients report significant reduction in quality of life due to poor sleep quality, excessive daytime fatigue, and disruption of partner's sleep quality due to chronic snoring. In addition, moderate to severe OSA is highly associated with hypertension, insulin resistance, dyslipidemia, vascular disease, and cardiac dysrhythmias [1], and is an independent risk factor for all-cause mortality [2].

https://ift.tt/2qJ3avD